Bicontinuous Morphologies in CART-Based RNA Delivery Nanoparticles

Study Background and Research Question

Nonviral gene delivery stands at the forefront of modern therapeutics, propelled by the urgent need for safe and efficient systems to transport mRNA and siRNA into target cells. While lipid nanoparticles (LNPs) have dominated clinical applications—most notably for mRNA vaccines—synthetic polymer-based alternatives are gaining attention due to their modularity and tunable properties. However, the fundamental principles governing the self-assembly of RNA with amphiphilic block copolymers, and the resultant nanoparticle structures, remain poorly defined. The reference study (Hurst et al., ACS Nano) addresses this knowledge gap by systematically examining how Charge-Altering Releasable Transporters (CARTs), a class of amphiphilic block copolymers, interact with RNA to form supramolecular assemblies with unique internal morphologies.

Key Innovation from the Reference Study

The pivotal contribution of Hurst et al. lies in their comprehensive structural and morphological characterization of CART-RNA nanoparticle assemblies. Previous work established CARTs as effective gene delivery agents due to their programmable cationic and lipophilic segments. This study advances the field by combining cryogenic electron microscopy (CryoEM), cryogenic electron tomography (CryoET), small-angle neutron scattering (SANS), and small-angle X-ray scattering (SAXS) to visualize and quantify the nanoscale organization of these delivery vehicles.

The authors demonstrate that low molar mass (≤10,000 g/mol) CART amphiphiles self-assemble with RNA to form nanoparticles exhibiting disordered, bicontinuous internal morphologies. These bicontinuous domains—comprising interpenetrating aqueous (coacervate) and lipid phases—contrast with the more homogeneous structures of canonical LNPs, suggesting new routes for cargo encapsulation and release.

Methods and Experimental Design Insights

To dissect the structure-function relationship of CART-based RNA delivery, the study employs a panel of amphiphilic block copolymers with systematically varied cationic and lipophilic block lengths and chemistries. The synthesis of CARTs relies on controlled ring-opening polymerization, followed by deprotection steps to yield cationic, charge-altering segments. These are then complexed with RNA (both mRNA and siRNA) under aqueous conditions to promote self-assembly.

Advanced imaging and scattering techniques underpin the structural analysis. CryoEM and CryoET provide high-resolution images of the internal architecture, while SANS and SAXS quantify domain spacing and morphological order. By varying the molar mass and block composition of CARTs, the authors correlate polymer characteristics with the resulting supramolecular organization and stability of the nanoparticles.

Protocol Parameters

• CART Synthesis: Lipid and cationic blocks synthesized via room-temperature ring-opening polymerization with tailored catalysts and monomer ratios as detailed in the reference study.
• RNA/CART Assembly: RNA mixed with CARTs in aqueous buffer; optimal N/P (nitrogen to phosphate) ratios and incubation times determined empirically for each formulation.
• Characterization: CryoEM and CryoET performed at liquid nitrogen temperatures to preserve native nanoparticle morphology; SANS/SAXS used for domain spacing measurements (typically 6–8 nm for bicontinuous assemblies).

Core Findings and Why They Matter

The study reveals several key insights:

• Bicontinuous Internal Morphology: Only low molar mass CARTs (≤10,000 g/mol) with appropriate block balance form nanoparticles characterized by interpenetrating, disordered aqueous and lipid domains. RNA is critical in driving this bicontinuous phase formation, an architecture associated with highly efficient encapsulation and controlled release.
• Cargo and Polymer Structure Dependency: The internal domain spacing and degree of morphological order depend sensitively on both the chemical structure of the CARTs and the nature of the oligonucleotide cargo (mRNA vs siRNA). For example, longer nucleic acid chains, such as mRNA, promote more extensive bicontinuous features compared to shorter siRNAs.
• Transition at Higher Molar Mass: CARTs with higher molar mass (≥28,000 g/mol) fail to generate bicontinuous assemblies, instead aggregating into small, roughly spherical particles (~10–20 nm). This delineates a design window for achieving optimal internal morphology for gene delivery applications.

These findings provide a blueprint for the rational design of polymer-based RNA delivery systems, where internal nanoparticle structure can be tuned to influence delivery efficiency, cargo release, and cellular uptake.

Comparison with Existing Internal Articles

Several internal resources expand on the practical implementation and functional readouts of mRNA delivery systems, particularly focusing on dual-fluorescent, immune-evasive capped mRNAs such as EZ Cap™ Cy5 EGFP mRNA (5-moUTP). For instance, the article "EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Dual-Fluorescent mRNA Benchmark" discusses how Cap 1 structures and 5-methoxyuridine modifications enhance mRNA stability and suppress RNA-mediated innate immune activation—critical for accurate translation efficiency assays. This aligns with the reference study's emphasis on the structural requirements for efficient mRNA encapsulation and delivery.

Moreover, "Advancing mRNA Delivery and Functional Genomics" provides scenario-driven strategies for optimizing functional genomics workflows, emphasizing the importance of tracking both mRNA delivery (via Cy5 fluorescence) and protein expression (via EGFP) as dual readouts. The reference paper's morphological insights offer a mechanistic basis for why certain polymeric formulations enable more reliable mRNA delivery and gene regulation and function studies.

Limitations and Transferability

While the study meticulously maps the structure-property relationships of CART-based RNA assemblies, several limitations remain. The experiments are conducted in vitro using model nucleic acids and purified polymers, which may not fully recapitulate the complexities of in vivo environments. The scalability and biocompatibility of specific CART formulations require further assessment prior to clinical translation. Additionally, the study does not directly address how these bicontinuous morphologies influence endosomal escape or long-term gene expression in cellular or animal models. Transferability to other amphiphilic polymer systems, or to natural mRNAs with extensive post-transcriptional modifications, should be validated experimentally.

Research Support Resources

For researchers aiming to extend these findings or benchmark new delivery systems, practical reagents such as EZ Cap™ Cy5 EGFP mRNA (5-moUTP) (SKU R1011) are available. This dual-fluorescent reporter mRNA, featuring a Cap 1 structure and 5-methoxyuridine modifications, enables quantitative visualization of mRNA uptake (via Cy5) and translation output (via EGFP fluorescence) in real time. Its design mirrors many of the delivery and detection challenges addressed in the reference study and can support workflows involving mRNA delivery and translation efficiency assays, suppression of RNA-mediated innate immune activation, and optimization of gene regulation studies. As always, researchers should adhere to recommended storage and handling protocols to maintain mRNA integrity during advanced delivery experiments.